Evidence for presence of insulin receptors in rat islets of Langerhans
- PMID: 6988459
- PMCID: PMC371457
- DOI: 10.1172/JCI109778
Evidence for presence of insulin receptors in rat islets of Langerhans
Abstract
Binding of insulin to islets of Langerhans was studied. It was found that "specific" binding of [125I]insulin ("specific" binding equals total binding minus nonspecific binding) was saturable with respect to time and insulin concentration and depended on the number of incubated islets. Furthermore, bound insulin was displaced by native insulin in a dose-dependent manner. Bound [125I]insulin was easily dissociated and there was little [125I]insulin degradation both in the incubation medium and during the processes of binding and dissociation. Scatchard analysis of experiments with increasing [125I]insulin concentration and with displacement of insulin binding by native insulin revealed "high affinity" binding sites with a dissociation constant of 0.461 +/- 0.08 n M and 3.5 X 10(6) high affinity binding sites per islet. There also existed "low affinity" binding sites with dissociation constant (Kd) of 43.9 +/- 11.6 nM and 5.9 X 10(7) low affinity binding sites. High affinity binding sites of islets from rats pretreated with alloxan decreased by about one half, whereas Kd was unaffected. Because the Kd of specific high affinity binding and mean effective dose (ED50) of the biological effects of insulin on normal pancreatic islets are in the same range (between 0.46 and 1.19 nM), the insulin-receptor interaction may be biologically significant.
Similar articles
-
Insulin binding and degradation in short time incubation at 37 C.Acta Physiol Pharmacol Latinoam. 1984;34(4):343-54. Acta Physiol Pharmacol Latinoam. 1984. PMID: 6242261
-
Identification and characterization of the insulin receptor in the R3230AC mammary adenocarcinoma of the rat.Cancer Res. 1976 Nov;36(11 Pt 1):3993-4000. Cancer Res. 1976. PMID: 135640
-
The characterization, regulation, and function of insulin receptors on osteoblast-like clonal osteosarcoma cell line.J Bone Miner Res. 1989 Dec;4(6):853-62. doi: 10.1002/jbmr.5650040610. J Bone Miner Res. 1989. PMID: 2692404
-
[Insulin receptors-a review (author's transl)].Diabete Metab. 1975 Mar;1:57-68. Diabete Metab. 1975. PMID: 791721 Review. French.
-
Identification of insulin binding sites in isolated cells from rat submaxillary gland.Arch Biol Med Exp. 1988 Jun;21(1):189-93. Arch Biol Med Exp. 1988. PMID: 3154859 Review.
Cited by
-
Anti-insulin antiserum increases inositol phosphate accumulation in rat pancreatic islets.Biochem J. 1990 Apr 15;267(2):339-42. doi: 10.1042/bj2670339. Biochem J. 1990. PMID: 2185741 Free PMC article.
-
Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro.Naunyn Schmiedebergs Arch Pharmacol. 1986 Mar;332(3):284-7. doi: 10.1007/BF00504868. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 3012373
-
Binding and internalization of somatostatin, insulin, and glucagon by cultured rat islet cells.J Clin Invest. 1989 Aug;84(2):412-7. doi: 10.1172/JCI114181. J Clin Invest. 1989. PMID: 2569474 Free PMC article.
-
Insulin inhibits its own secretion from isolated, perifused human pancreatic islets.Acta Diabetol. 1995 Jun;32(2):75-7. doi: 10.1007/BF00569560. Acta Diabetol. 1995. PMID: 7579537
-
Atrial natriuretic peptide (ANP) acts via specific binding sites on cGMP system of rat pancreatic islets without affecting insulin release.Naunyn Schmiedebergs Arch Pharmacol. 1989 Mar;339(3):348-53. doi: 10.1007/BF00173590. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2542810
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources